<DOC>
	<DOCNO>NCT01854229</DOCNO>
	<brief_summary>The Prometra Pump approve FDA use United States . The purpose study collect long-term safety data Prometra Pump .</brief_summary>
	<brief_title>Prometra Post-Approval Study</brief_title>
	<detailed_description>This study propose part post-Premarket Approval ( PMA ) requirement . This study prospective , non-randomized , open-label , multicenter study . It perform 10-30 center US enroll maximum 400 subject . Subjects follow total five year .</detailed_description>
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Pain , Intractable</mesh_term>
	<criteria>1 . Patient meet least one following : suffer malignant pain ( i.e. , cancer pain ) chronic , nonmalignant pain subject enrol PUMP I PUMP II study chooses participate PostApproval study Patient exist implantable pump pain therapy require replacement 2 . Patient least 22 year age . 3 . Investigator considers patient able willing fulfill study requirement . 4 . Patient provide write informed consent participate study . 1 . Patient meet contraindication use Prometra System 2 . Patient prior history granuloma formation , receive treatment suspect granuloma . 3 . Patient pregnant breastfeed childbearing potential employ effective birth control .</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Morphine</keyword>
	<keyword>Implantable Infusion Pumps</keyword>
	<keyword>Intrathecal Pump</keyword>
</DOC>